Document Detail


Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells.
MedLine Citation:
PMID:  20964644     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The anti-hypertensive drug captopril is used commonly to reduce blood pressure of patients with severe forms of Chagas disease, a cardiomyopathy caused by chronic infection with the intracellular protozoan Trypanosoma cruzi. Captopril acts by inhibiting angiotensin-converting enzyme (ACE), the vasopressor metallopeptidase that generates angiotensin II and promotes the degradation of bradykinin (BK). Recent studies in mice models of Chagas disease indicated that captopril can potentiate the T helper type 1 (Th1)-directing natural adjuvant property of BK. Equipped with kinin-releasing cysteine proteases, T. cruzi trypomastigotes were shown previously to invade non-professional phagocytic cells, such as human endothelial cells and murine cardiomyocytes, through the signalling of G protein-coupled bradykinin receptors (B(2) KR). Monocytes are also parasitized by T. cruzi and these cells are known to be important for the host immune response during infection. Here we showed that captopril increases the intensity of T. cruzi infection of human monocytes in vitro. The increased parasitism was accompanied by up-regulated expression of ACE in human monocytes. While T. cruzi infection increased the expression of interleukin (IL)-10 by monocytes significantly, compared to uninfected cells, T. cruzi infection in association with captopril down-modulated IL-10 expression by the monocytes. Surprisingly, studies with peripheral blood mononuclear cells revealed that addition of the ACE inhibitor in association with T. cruzi increased expression of IL-17 by CD4(+) T cells in a B(2) KR-dependent manner. Collectively, our results suggest that captopril might interfere with host-parasite equilibrium by enhancing infection of monocytes, decreasing the expression of the modulatory cytokine IL-10, while guiding development of the proinflammatory Th17 subset.
Authors:
J S Coelho dos Santos; C A S Menezes; F N A Villani; L M D Magalhães; J Scharfstein; K J Gollob; W O Dutra
Related Documents :
21281514 - Evaluation of transduction efficiency in macrophage colony-stimulating factor different...
6807834 - In vitro induction of intracellular killing of parasitic protozoa by macrophages.
15463754 - The flagellar pocket of trypanosomatids.
8167574 - Endocrine and neuroendocrine host-parasite relationships.
19264704 - Induction of cellular senescence by secretory phospholipase a2 in human dermal fibrobla...
23238564 - Sign-r1, a c-type lectin, enhances apoptotic cell clearance through the complement depo...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-10-21
Journal Detail:
Title:  Clinical and experimental immunology     Volume:  162     ISSN:  1365-2249     ISO Abbreviation:  Clin. Exp. Immunol.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-12     Completed Date:  2011-03-08     Revised Date:  2013-05-27    
Medline Journal Info:
Nlm Unique ID:  0057202     Medline TA:  Clin Exp Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  528-36     Citation Subset:  IM    
Copyright Information:
© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology.
Affiliation:
Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
CD4-Positive T-Lymphocytes / drug effects*,  immunology,  metabolism,  parasitology,  pathology
Captopril / pharmacology*
Cells, Cultured
Chagas Disease / drug therapy*,  immunology,  parasitology,  physiopathology
Gene Expression Regulation
Host-Parasite Interactions / drug effects
Humans
Inflammation Mediators / metabolism
Interleukin-10 / biosynthesis,  genetics
Interleukin-17 / genetics,  metabolism
Male
Monocytes / drug effects*,  immunology,  metabolism,  parasitology,  pathology
Renin-Angiotensin System / drug effects
Th1-Th2 Balance
Trypanosoma cruzi / immunology*,  pathogenicity
Virulence / drug effects
Grant Support
ID/Acronym/Agency:
R03 AI066044-03/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Inflammation Mediators; 0/Interleukin-17; 130068-27-8/Interleukin-10; 62571-86-2/Captopril
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The interferon-alpha and interleukin-10 responses in neonates differ from adults, and their producti...
Next Document:  Long-term follow-up of patients with type 1 diabetes transplanted with neonatal pig islets.